Putative druggable targets for selective enhancement of cardiac conduction.

Abstract:

:Putative druggable targets to selectively enhance cardiac conduction can be considered from the level of the ion channels determining the initiation and duration of the cardiac action potential to the gap junction proteins responsible for optimal cellular electrical coupling. Nature has provided a number of inherited disorders of conduction, the pathophysiology of which offer novel insights into future therapeutic targets. This review will focus upon the potential cellular and molecular targets for drug development based upon our knowledge of their pathophysiological impact.

journal_name

Curr Opin Pharmacol

authors

Gomes J,Lambiase PD

doi

10.1016/j.coph.2008.11.008

subject

Has Abstract

pub_date

2009-04-01 00:00:00

pages

154-9

issue

2

eissn

1471-4892

issn

1471-4973

pii

S1471-4892(08)00194-X

journal_volume

9

pub_type

杂志文章
  • Importance of Ca(2+) in gastric epithelial restitution-new views revealed by real-time in vivo measurements.

    abstract::It has been a few decades since Ca(2+) was identified as one of the important factors that can accelerate gastric wound repair as well as contribute to epithelial homeostasis and regulation of gastric secretions. The mechanistic basis has remained largely unexplored in vivo because it was not possible to track in real...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.07.012

    authors: Aihara E,Montrose MH

    更新日期:2014-12-01 00:00:00

  • GABA(A)-receptor subtypes: a new pharmacology.

    abstract::The GABA(A) receptor is a pluripotent drug target mediating anxiolytic, sedative, anticonvulsant, muscle relaxant and amnesic activity. These drug actions have now been attributed to defined receptor subtypes. Thus, precise guidelines are available for the development of novel drugs with more selective action and less...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00008-x

    authors: Möhler H,Crestani F,Rudolph U

    更新日期:2001-02-01 00:00:00

  • Thrombomodulation via CLEC-2 targeting.

    abstract::CLEC-2 is a C-type lectin-like molecule that has recently been identified as a receptor on the surface of platelets. Ligand binding by CLEC-2 promotes phosphorylation of a tyrosine in the cytoplasmic domain YXXL motif of CLEC-2 by Src kinases and further downstream signalling events trigger platelet activation and agg...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.11.001

    authors: O'Callaghan CA

    更新日期:2009-04-01 00:00:00

  • New pathways to control inflammatory responses in adipose tissue.

    abstract::Obesity is characterized by the presence of chronic inflammation in adipose tissue, particularly in the visceral compartment, that has been causally linked to development of obesity-associated comorbidities. This link can be either direct or indirect, through induction of insulin resistance. This review summarizes rec...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.04.008

    authors: Akasheh RT,Pang J,York JM,Fantuzzi G

    更新日期:2013-08-01 00:00:00

  • Aptamers as candidate therapeutics for cardiovascular indications.

    abstract::The first therapeutic aptamer was approved for human use in 2004, and a range of chemical substitutions that improve the drug-like properties of aptamers has recently been shown to increase the utility of this modality. Currently there are both anticoagulant and antithrombotic aptamers in the clinic, and additionally ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.12.005

    authors: Keefe AD,Schaub RG

    更新日期:2008-04-01 00:00:00

  • Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors.

    abstract::Recent advances in the development of potent and selective peptide and non-peptide ligands for peptidergic receptors are anticipated to help further unravel the roles of class I and II G-protein-coupled receptors in the pathogenesis of human diseases and to accelerate the clinical utility of small molecule peptidomime...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.06.003

    authors: Jones RM,Boatman PD,Semple G,Shin YJ,Tamura SY

    更新日期:2003-10-01 00:00:00

  • Promoting apoptosis in disease management: a panacea or Trojan horse?

    abstract::In our enthusiasm to advocate apoptosis as a therapeutic strategy for the management of disease we need to be mindful that the clearance of apoptotic cells is itself immunomodulatory and that it may not always be as benign or beneficial as we think. Indeed, the existence of free apoptotic cells in situ may potentially...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.02.005

    authors: Brown SB,Vernon-Wilson EF

    更新日期:2005-08-01 00:00:00

  • MicroRNA involvement in esophageal carcinogenesis.

    abstract::MicroRNAs (miRs) have recently emerged as a novel class of gene expression regulators. The number of studies documenting an altered miR expression pattern in cancer continues to expand rapidly. Critical information is continuously gained regarding how aberrantly expressed miRs contribute to carcinogenesis. Current stu...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.09.006

    authors: David S,Meltzer SJ

    更新日期:2011-12-01 00:00:00

  • The brain hypocretins and their receptors: mediators of allostatic arousal.

    abstract::The hypocretins (abbreviated 'Hcrts' - also called 'orexins') are two neuropeptides secreted exclusively by a small population of neurons in the lateral hypothalamus. These peptides bind to two receptors located throughout the brain in nuclei associated with diverse cognitive and physiological functions. Initially, th...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.12.018

    authors: Carter ME,Schaich Borg J,de Lecea L

    更新日期:2009-02-01 00:00:00

  • Retrieving GPCR data from public databases.

    abstract::Improvements in databases have already impacted GPCR research. The purpose of the review is to give a snapshot of the GPCR data available and provide utility examples. Consequently, this review covers a small set of major databases, including UniProt for proteins, Ensembl for genes, ChEMBL for bioactive chemistry and ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.07.002

    authors: Southan C

    更新日期:2016-10-01 00:00:00

  • New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases.

    abstract::Chronic liver diseases with different etiologies represent a major public health issue worldwide. Liver fibrosis is the common feature of almost all chronic liver diseases and remains a key determinant of clinical prognosis. Over the last two decades, basic science studies have uncovered molecular mechanisms underlyin...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.09.006

    authors: Lemoinne S,Friedman SL

    更新日期:2019-12-01 00:00:00

  • HIV protease inhibitors in gut barrier dysfunction and liver injury.

    abstract::The development of HIV protease inhibitors (HIV PIs) has been one of the most significant advances of the past two decades in controlling HIV infection. HIV PIs have been used successfully in highly active anti-retroviral therapy (HAART) for HIV infection, which is currently the most effective treatment available. Inc...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.07.008

    authors: Wu X,Li Y,Peng K,Zhou H

    更新日期:2014-12-01 00:00:00

  • Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite.

    abstract::The deployment of artemisinin-based combination therapies (ACTs) has been, and continues to be, integral to reducing the number of malaria cases and deaths. However, their efficacy is being increasingly jeopardized by the emergence and spread of parasites that are resistant (or partially resistant) to the artemisinin ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.07.010

    authors: Martin RE,Shafik SH,Richards SN

    更新日期:2018-10-01 00:00:00

  • The study of airway primary afferent neuron excitability.

    abstract::The activation of airway afferent neurons initiates a variety of reflexes including cough and bronchoconstriction. Like somatic afferent neurons involved in inflammation-induced hyperalgesia, the excitability of airway afferent neurons is not fixed but, rather, can be increased by the action of a variety of mediators ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00147-9

    authors: Carr MJ,Ellis JL

    更新日期:2002-06-01 00:00:00

  • Germ-free animal experiments in the gut microbiota studies.

    abstract::Gut microbiota has a crucial role in the maintenance of health. Increasing evidence suggests that changes or disturbances in gut microbiota may be associated with various diseases. Therefore, preclinical and clinical studies related to gut microbiota are becoming increasingly important. Germ-free animal experimentatio...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.03.016

    authors: Uzbay T

    更新日期:2019-12-01 00:00:00

  • Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.

    abstract::Phosphodiesterase-5 (PDE5) inhibitors and other agents that modulate intracellular cGMP are now emerging as promising, safe, and easy to administer therapies for pulmonary hypertension, with relatively few side effects. Recent studies have shown that PDE5 inhibitors are potent acute pulmonary vasodilators in experimen...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.12.008

    authors: Steiner MK,Preston IR,Klinger JR,Hill NS

    更新日期:2005-06-01 00:00:00

  • Gene expression profiling in stroke: relevance of blood-brain interaction.

    abstract::Biomarker profiling is utilized to identify diagnostic and prognostic candidates for stroke. Clinical and preclinical biomarker data suggest altered circulating immune responses may illuminate the mechanisms of stroke recovery. However, the relationship between peripheral blood biomarker profile(s) and brain profiles ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.10.004

    authors: Asano S,Chantler PD,Barr TL

    更新日期:2016-02-01 00:00:00

  • Therapeutic opportunities in the B7/CD28 family of ligands and receptors.

    abstract::The CD28 and B7 protein families are critical regulators of immune responses and, in the past few years, several new family members have been identified. Preclinical studies exploring the role of members of the CD28 and B7 families support the targeting of these pathways for new therapeutic approaches. Indeed, recent ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.02.003

    authors: Carreno BM,Carter LL,Collins M

    更新日期:2005-08-01 00:00:00

  • Targeting metabotropic glutamate receptors in the treatment of primary brain tumors.

    abstract::In spite of the recent advancement in the molecular characterization of malignant gliomas and medulloblastomas, the treatment of primary brain tumors remains suboptimal. The use of small molecule inhibitors of intracellular signaling pathways, inhibitors of angiogenesis, and immunotherapic agents is limited by systemi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.02.005

    authors: Iacovelli L,Orlando R,Rossi A,Spinsanti P,Melchiorri D,Nicoletti F

    更新日期:2018-02-01 00:00:00

  • Heart failure and diabetes: role of ATM.

    abstract::Heart failure is a leading cause of death in the United States. Diabetes, also known as diabetes mellitus (DM), exponentially increases the risk of heart failure. The increase in oxidative stress and metabolic dysfunction caused by DM can lead to DNA damage and the development of diabetic cardiomyopathy. Ataxia telang...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2020.06.007

    authors: Wingard MC,Frasier CR,Singh M,Singh K

    更新日期:2020-10-01 00:00:00

  • Promising pharmacologic innovations in treating pulmonary fibrosis.

    abstract::Idiopathic pulmonary fibrosis is the most common form of the interstitial lung diseases and is characterized by chronic progressive pulmonary parenchymal fibrosis. Although the diagnosis and pathophysiology of this disease have been better characterized over the past few years, there remains no effective therapy for t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.003

    authors: Bhatt N,Baran CP,Allen J,Magro C,Marsh CB

    更新日期:2006-06-01 00:00:00

  • The bacterial ribosome, a promising focus for structure-based drug design.

    abstract::Recent crystal structures of the bacterial ribosome have identified the complex molecular interactions involved in antibiotic-ribosome recognition. Insights into the binding of aminoglycosides, macrolides, tetracyclines and other antibiotics provide opportunities for computational, structure-based approaches to be use...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00205-9

    authors: Knowles DJ,Foloppe N,Matassova NB,Murchie AI

    更新日期:2002-10-01 00:00:00

  • Controlling ionotropic and metabotropic glutamate receptors with light: principles and potential.

    abstract::Light offers unique advantages for studying and manipulating biomolecules and the cellular processes that they control. Optical control of ionotropic and metabotropic glutamate receptors has garnered significant interest, since these receptors are central to signaling at neuronal synapses and only optical approaches p...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.12.008

    authors: Reiner A,Levitz J,Isacoff EY

    更新日期:2015-02-01 00:00:00

  • VEGF as a potential target for therapeutic intervention in depression.

    abstract::Antidepressants are among the most widely prescribed drugs, however the mechanism underlying their therapeutic efficacy is not known. Neurotrophic factors represent a promising class of targets for antidepressant treatments. We recently characterized a role for vascular endothelial growth factor (VEGF) in cellular and...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.10.013

    authors: Warner-Schmidt JL,Duman RS

    更新日期:2008-02-01 00:00:00

  • PDE inhibitors: a new approach to treat metabolic syndrome?

    abstract::About one third of people in the world suffer from metabolic syndrome (MetS), with symptoms such as hypertension and elevated blood cholesterol, and with increased risk of developing additional diseases such as diabetes mellitus and heart disease. The progression of this multifactorial pathology, which targets various...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.09.012

    authors: Lugnier C

    更新日期:2011-12-01 00:00:00

  • Airway nerves: in vivo electrophysiology.

    abstract::Information about the activity of airway sensory afferent nerves in vivo can be obtained electrophysiologically by extracellular recording of action potentials. Apart from data capture, the basic techniques used for recording sensory nerve activity have not advanced greatly in 50 years. However, clearly they continue ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00153-4

    authors: Adcock JJ

    更新日期:2002-06-01 00:00:00

  • Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens.

    abstract::The non-nucleoside reverse transcriptase inhibitors (NNRTIs) are allosteric inhibitors of HIV-1 reverse transcriptase and are classified into generations depending on their discovery and resistance profiles. The NNRTIs are used in combination regimens with antiretroviral agents that target two or more enzymes in the v...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2020.10.009

    authors: Vanangamudi M,Kurup S,Namasivayam V

    更新日期:2020-10-01 00:00:00

  • Pharmacological chaperone action on G-protein-coupled receptors.

    abstract::An increasing number of genetic diseases are found to result from mutations that lead to retention of the affected proteins in the endoplasmic reticulum, where they are recognized as misfolded by the quality control system. Several of these conformational diseases involve mutations in G-protein-coupled receptors. Rece...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.08.001

    authors: Bernier V,Bichet DG,Bouvier M

    更新日期:2004-10-01 00:00:00

  • Antiviral therapeutics for the treatment of Ebola virus infection.

    abstract::There have been significant developments in Ebola virus therapeutics. While the efficacy of several products was evaluated in the recent West Africa outbreak, a licensed treatment for EBOV disease remains elusive. Factors that negatively impacted the execution of clinical trials included an overall lack of world readi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.08.016

    authors: Cardile AP,Downey LG,Wiseman PD,Warren TK,Bavari S

    更新日期:2016-10-01 00:00:00

  • Neurotrophic effects of antidepressant drugs.

    abstract::The past decade has witnessed a growing interest in the trophic effects of antidepressant drugs. Antidepressants stimulate the production and signaling of plasticity-related proteins such as neurotrophins and cAMP response element binding protein, and neurotrophin signaling appears to be both sufficient and necessary ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.10.004

    authors: Castrén E

    更新日期:2004-02-01 00:00:00